Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031

1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.3 STUDY SCOPE 35 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 36 1.3.2 INCLUSIONS & EXCLUSIONS 37 1.3.3 YEARS CONSIDERED 38 1.4 MARKET STAKEHOLDERS 38 1.5 LIMITATIONS 39 1.6 SUMMARY OF CHANGES 39 2 EXECUTIVE SUMMARY 41 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 41 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 42 2.3 DISRUPTIVE TRENDS IN GASTROINTESTINAL STENTS MARKET 43 2.4 HIGH-GROWTH SEGMENTS 44 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 45 3 PREMIUM INSIGHTS 47 3.1 GASTROINTESTINAL STENTS MARKET OVERVIEW 47 3.2 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE AND COUNTRY (2025) 48 3.3 GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49 3.4 GASTROINTESTINAL STENTS MARKET: REGIONAL MIX (2026−2031) 49 3.5 GASTROINTESTINAL STENTS MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 50 4 MARKET OVERVIEW 51 4.1 INTRODUCTION 51 4.2 MARKET DYNAMICS 51 4.2.1 DRIVERS 52 4.2.1.1 Rising burden of GI cancers and pancreaticobiliary diseases 52 4.2.1.2 Growing preference for minimally invasive endoscopic palliation 53 4.2.1.3 Technological advancements in GI stents 53 4.2.1.4 Expanding use of SEMS over plastic stents 54 4.2.2 RESTRAINTS 55 4.2.2.1 High device and procedure costs 55 4.2.2.2 Risk of stent migration, perforation, bleeding, and re-obstruction 56 4.2.3 OPPORTUNITIES 56 4.2.3.1 Rising adoption in emerging markets 56 4.2.3.2 Expansion of EUS-guided stenting procedures 57 4.2.4 CHALLENGES 57 4.2.4.1 Need for high operator expertise 57 4.2.4.2 Regulatory and post-market safety scrutiny 58 4.3 UNMET NEEDS & WHITE SPACES 59 4.3.1 UNMET NEEDS IN GASTROINTESTINAL STENTS MARKET 59 4.3.2 WHITE SPACE OPPORTUNITIES 59 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 60 4.4.1 INTERCONNECTED MARKETS 60 4.4.2 CROSS-SECTOR OPPORTUNITIES 61 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61 5 INDUSTRY TRENDS 63 5.1 PORTER’S FIVE FORCES ANALYSIS 63 5.1.1 THREAT OF NEW ENTRANTS 64 5.1.2 THREAT OF SUBSTITUTES 64 5.1.3 BARGAINING POWER OF SUPPLIERS 64 5.1.4 BARGAINING POWER OF BUYERS 65 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 65 5.2 MACROECONOMIC INDICATORS 66 5.2.1 INTRODUCTION 66 5.2.2 GDP TRENDS & FORECAST 66 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 67 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 67 5.3 VALUE CHAIN ANALYSIS 68 5.4 ECOSYSTEM ANALYSIS 69 5.5 PRICING ANALYSIS 70 5.5.1 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023–2025 71 5.5.1.1 Average selling price trend of gastrointestinal stents, by key player, 2023−2025 71 5.5.2 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY REGION, 2023–2025 73 5.5.2.1 Average selling price trend of nitinol stents, by region, 2023−2025 74 5.5.2.2 Average selling price trend of stainless-steel stents, by region, 2023−2025 74 5.5.2.3 Average selling price trend of plastic stents, by region, 2023−2025 74 5.6 TRADE ANALYSIS 75 5.6.1 TRADE DATA FOR HS CODE 9018 75 5.6.1.1 Import data for HS Code 9018 75 5.6.1.2 Export data for HS Code 9018 76 5.6.2 TRADE DATA FOR HS CODE 9021 76 5.6.2.1 Import data for HS Code 9021 76 5.6.2.2 Export data for HS Code 9021 77 5.7 KEY CONFERENCES & EVENTS, 2026–2027 77 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78 5.9 INVESTMENT & FUNDING SCENARIO 79 5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS 80 5.10.1 COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION 80 5.10.2 DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION 80 5.10.3 LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION 81 5.11 IMPACT OF 2025 US TARIFFS ON GASTROINTESTINAL STENTS MARKET 81 5.11.1 INTRODUCTION 81 5.11.2 KEY TARIFF RATES 83 5.11.3 PRICE IMPACT ANALYSIS 84 5.11.4 IMPACT ON COUNTRY/REGION 84 5.11.5 IMPACT ON END-USE INDUSTRIES 86 5.11.5.1 Hospitals & clinics 86 5.11.5.2 Specialty endoscopy centers/GI clinics 86 5.11.5.3 Ambulatory surgical centers 87 6 SUSTAINABILITY & REGULATORY LANDSCAPE 88 6.1 REGIONAL REGULATIONS & COMPLIANCE 88 6.1.1 REGULATORY ANALYSIS 88 6.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 6.1.3 INDUSTRY STANDARDS 91 6.2 SUSTAINABILITY INITIATIVES 92 6.2.1 RECYCLED & ECO-FRIENDLY MATERIALS FOR GASTROINTESTINAL STENTS 92 6.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 93 6.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 93 7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94 7.1 KEY STAKEHOLDERS & BUYING CRITERIA 94 7.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 7.1.2 BUYING CRITERIA 95 7.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96 7.2.1 DECISION-MAKING PROCESS 96 7.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 97 7.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 97 7.2.4 MARKET PROFITABILITY 98   8 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 99 8.1 TECHNOLOGY ANALYSIS 99 8.1.1 KEY EMERGING TECHNOLOGIES 99 8.1.1.1 Biodegradable gastrointestinal stents 99 8.1.1.2 3D-printed personalized stents 100 8.1.2 COMPLEMENTARY TECHNOLOGIES 101 8.1.2.1 Advanced endoscopic imaging & AI-assisted endoscopy 101 8.1.2.2 Minimally invasive surgical devices 101 8.1.3 ADJACENT TECHNOLOGIES 102 8.1.3.1 Surface modification technologies 102 8.1.3.2 Nitinol alloy technology 102 8.2 TECHNOLOGY/PRODUCT ROADMAP 103 8.2.1 NEAR TERM (2025–2027) 103 8.2.2 MID TERM (2028–2030) 103 8.2.3 LONG TERM (2030+) 104 8.3 PATENT ANALYSIS 104 8.3.1 PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS 104 8.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 105 8.4 FUTURE APPLICATIONS 107 8.4.1 AI-ASSISTED ENDOSCOPY & STENT PLACEMENT 107 8.4.2 NEXT-GENERATION BIODEGRADABLE GI STENTS 107 8.4.3 PERSONALIZED & 3D-PRINTED GI STENTS 108 8.4.4 DRUG-ELUTING & SMART GI STENTS 108 8.4.5 ROBOTIC-ASSISTED & IMAGE-GUIDED GI INTERVENTIONS 108 8.5 IMPACT OF AI/GENERATIVE AI ON GASTROINTESTINAL STENTS MARKET 108 8.5.1 INTRODUCTION 108 8.5.2 MARKET POTENTIAL IN GASTROINTESTINAL STENTS ECOSYSTEM 108 8.5.3 AI USE CASES 109 8.5.4 KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET 109 9 GASTROINTESTINAL STENTS MARKET, BY PRODUCT 111 9.1 INTRODUCTION 112 9.2 BILIARY STENTS 113 9.2.1 RISING BURDEN OF HEPATOBILIARY AND PANCREATIC DISORDERS TO BOOST DEMAND 113 9.3 ESOPHAGEAL STENTS 116 9.3.1 INCREASING ESOPHAGEAL CANCER INCIDENCE TO DRIVE MARKET 116 9.4 COLONIC STENTS 118 9.4.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE MANAGEMENT OF COLORECTAL OBSTRUCTIONS TO DRIVE MARKET 118   9.5 DUODENAL STENTS 120 9.5.1 EXPANDING USE OF ENDOSCOPIC PALLIATION TO FUEL MARKET GROWTH 120 9.6 PANCREATIC STENTS 122 9.6.1 RISING VOLUME OF ERCP PROCEDURES AND PANCREATIC DISEASE MANAGEMENT TO SUPPORT GROWTH 122 10 GASTROINTESTINAL STENTS MARKET, BY TYPE 124 10.1 INTRODUCTION 125 10.2 METAL STENTS 125 10.2.1 METAL STENTS MARKET, BY TYPE 128 10.2.1.1 Nitinol stents 128 10.2.1.1.1 Growing demand for flexible and conformable stents to fuel demand 128 10.2.1.1.2 Global volume analysis of nitinol stents, 2024–2031 (thousand units) 130 10.2.1.2 Stainless steel stents 130 10.2.1.2.1 Increasing need for high radial force solutions to support adoption 130 10.2.1.2.2 Global volume analysis of stainless steel stents, 2024–2031 (thousand units) 132 10.2.1.3 Other metal stents 132 10.2.2 METAL STENTS MARKET, BY MECHANISM 134 10.2.2.1 Self-expanding metal stents (SEMS) 134 10.2.2.1.1 Expanding preference for minimally invasive cancer palliation to drive market growth 134 10.2.2.2 Balloon-expandable metal stents (BEMS) 136 10.2.2.2.1 Rising demand for precise stent deployment to support growth 136 10.2.3 METAL STENTS MARKET, BY COVERAGE 137 10.2.3.1 Uncovered stents 137 10.2.3.1.1 Growing use in malignant biliary obstruction management to support adoption 137 10.2.3.2 Fully covered stents 139 10.2.3.2.1 Greater focus on preventing tissue ingrowth to fuel adoption 139 10.2.3.3 Partially covered stents 141 10.2.3.3.1 Increasing emphasis on balancing patency and migration control to boost demand 141 10.3 PLASTIC STENTS 143 10.3.1 INCREASING VOLUME OF TEMPORARY BILIARY AND PANCREATIC DRAINAGE PROCEDURES TO DRIVE DEMAND 143 10.3.2 GLOBAL VOLUME ANALYSIS OF PLASTIC STENTS, 2024–2031 (THOUSAND UNITS) 145 10.4 BIODEGRADABLE STENTS 145 10.4.1 GLOBAL VOLUME ANALYSIS OF BIODEGRADABLE STENTS, 2024–2031 (THOUSAND UNITS) 148 10.4.2 POLYMER-BASED BIODEGRADABLE STENTS 148 10.4.2.1 Rising utilization in benign stricture treatment to support growth 148 10.4.3 MAGNESIUM-BASED BIODEGRADABLE STENTS 150 10.4.3.1 Advancements in bioresorbable metal technologies to drive market growth 150 10.4.4 OTHER BIODEGRADABLE STENTS 152 11 GASTROINTESTINAL STENTS MARKET, BY APPLICATION 154 11.1 INTRODUCTION 155 11.2 GASTROINTESTINAL CANCER 155 11.2.1 PANCREATIC CANCER 157 11.2.1.1 Increasing pancreatic cancer burden to support growth 157 11.2.2 COLORECTAL CANCER 159 11.2.2.1 Rising colorectal cancer incidence to drive demand 159 11.2.3 ESOPHAGEAL CANCER 161 11.2.3.1 Growing need for dysphagia relief to accelerate esophageal stent adoption 161 11.2.4 STOMACH CANCER 163 11.2.4.1 Expanding use of minimally invasive palliation to boost market growth 163 11.3 BILIARY DISEASE 164 11.3.1 INCREASING PREVALENCE OF BILIARY OBSTRUCTIONS TO ACCELERATE MARKET GROWTH 164 11.4 BENIGN STRICTURES & LEAKS 166 11.4.1 GROWING ADOPTION OF ENDOSCOPIC MANAGEMENT OF BENIGN GI CONDITIONS TO FUEL MARKET GROWTH 166 11.5 OTHER APPLICATIONS 168 12 GASTROINTESTINAL STENTS MARKET, BY END USER 170 12.1 INTRODUCTION 171 12.2 HOSPITALS & CLINICS 171 12.2.1 RISING GASTROINTESTINAL CANCER BURDEN AND ADVANCED ENDOSCOPY CAPABILITIES TO DRIVE MARKET GROWTH 171 12.3 SPECIALTY ENDOSCOPY CENTERS/GI CLINICS 173 12.3.1 GROWING PREFERENCE FOR SPECIALIZED THERAPEUTIC ENDOSCOPY TO PROPEL MARKET 173 12.4 AMBULATORY SURGICAL CENTERS 175 12.4.1 SHIFT TOWARD OUTPATIENT MINIMALLY INVASIVE PROCEDURES TO FUEL GROWTH 175 13 GASTROINTESTINAL STENTS MARKET, BY REGION 177 13.1 INTRODUCTION 178 13.2 NORTH AMERICA 179 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 180 13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 181 13.2.3 US 184 13.2.3.1 High GI disease burden and procedural volume to support adoption of GI stents 184 13.2.4 CANADA 189 13.2.4.1 Expanding minimally invasive GI interventions and aging demographics to drive market 189 13.3 EUROPE 193 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 194 13.3.2 EUROPE: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 194 13.3.3 GERMANY 198 13.3.3.1 Germany to dominate European market 198 13.3.4 UK 202 13.3.4.1 Expanding NHS adoption of innovative devices to support market growth 202 13.3.5 FRANCE 207 13.3.5.1 Strong focus on advanced GI treatments and reimbursement coverage to boost adoption 207 13.3.6 ITALY 211 13.3.6.1 Growing preference for minimally invasive procedures to drive market penetration 211 13.3.7 SPAIN 215 13.3.7.1 Expanding endoscopy infrastructure to fuel gradual market growth 215 13.3.8 NETHERLANDS 219 13.3.8.1 Advanced gastroenterology services and increasing GI cancer burden to boost adoption 219 13.3.9 SWEDEN 223 13.3.9.1 High healthcare expenditure to fuel market growth 223 13.3.10 POLAND 227 13.3.10.1 Rising cancer incidence and modernization of endoscopy services to boost market 227 13.3.11 REST OF EUROPE 231 13.4 ASIA PACIFIC 234 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 235 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 236 13.4.3 CHINA 240 13.4.3.1 China to dominate APAC market 240 13.4.4 JAPAN 244 13.4.4.1 Aging population and advanced endoscopy ecosystem to fuel market growth 244 13.4.5 INDIA 249 13.4.5.1 Growing cancer incidence and improving healthcare access to boost market growth 249 13.4.6 AUSTRALIA 253 13.4.6.1 Mature healthcare system and favorable regulatory pathways to enable early adoption 253 13.4.7 SOUTH KOREA 257 13.4.7.1 High screening rates and advanced clinical capabilities to boost market growth 257 13.4.8 THAILAND 261 13.4.8.1 Increasing colorectal and hepatobiliary cancer cases to support market growth 261 13.4.9 NEW ZEALAND 266 13.4.9.1 Expanding elderly population and strong cancer care services to boost demand 266 13.4.10 REST OF ASIA PACIFIC 270 13.5 LATIN AMERICA 273 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 274 13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 275 13.5.3 BRAZIL 278 13.5.3.1 Large patient population and rising colorectal cancer cases to propel market demand 278 13.5.4 MEXICO 283 13.5.4.1 Growing endoscopy capacity and disease burden to support steady market growth 283 13.5.5 ARGENTINA 287 13.5.5.1 Increasing gastrointestinal cancer incidence and advanced clinical capabilities to drive growth 287 13.5.6 REST OF LATIN AMERICA 291 13.6 MIDDLE EAST & AFRICA 294 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 295 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 295 13.6.3 GCC COUNTRIES 299 13.6.3.1 Kingdom of Saudi Arabia (KSA) 303 13.6.3.1.1 Healthcare transformation initiatives and rising cancer prevalence to fuel market expansion 303 13.6.3.2 United Arab Emirates (UAE) 307 13.6.3.2.1 Medical tourism growth and advanced healthcare investments to strengthen adoption 307 13.6.3.3 Rest of GCC Countries 311 13.6.4 REST OF MIDDLE EAST & AFRICA 315 14 COMPETITIVE LANDSCAPE 319 14.1 INTRODUCTION 319 14.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET 319   14.2 REVENUE ANALYSIS, 2023–2025 321 14.3 MARKET SHARE ANALYSIS, 2025 322 14.3.1 US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025 324 14.3.2 EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025 324 14.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 325 14.4.1 STARS 325 14.4.2 EMERGING LEADERS 325 14.4.3 PERVASIVE PLAYERS 325 14.4.4 PARTICIPANTS 325 14.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 327 14.4.5.1 Company footprint 327 14.4.5.2 Region footprint 328 14.4.5.3 Product footprint 329 14.4.5.4 Type footprint 329 14.5 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025 330 14.5.1 PROGRESSIVE COMPANIES 330 14.5.2 RESPONSIVE COMPANIES 330 14.5.3 DYNAMIC COMPANIES 330 14.5.4 STARTING BLOCKS 330 14.5.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2025 332 14.5.5.1 Detailed list of key start-ups/SMEs 332 14.5.5.2 Competitive benchmarking of start-ups/SMEs 333 14.6 COMPANY VALUATION & FINANCIAL METRICS 334 14.6.1 FINANCIAL METRICS 334 14.6.2 COMPANY VALUATION 334 14.7 PRODUCT/BRAND COMPARISON 335 14.8 COMPETITIVE SCENARIO 336 15 COMPANY PROFILES 340 15.1 KEY PLAYERS 340 15.1.1 BOSTON SCIENTIFIC CORPORATION 340 15.1.1.1 Business overview 340 15.1.1.2 Products offered 341 15.1.1.3 MnM view 342 15.1.1.3.1 Right to win 342 15.1.1.3.2 Strategic choices 342 15.1.1.3.3 Weaknesses & competitive threats 343 15.1.2 COOK MEDICAL 344 15.1.2.1 Business overview 344 15.1.2.2 Products offered 345 15.1.2.3 Recent developments 346 15.1.2.3.1 Other developments 346 15.1.2.4 MnM view 346 15.1.2.4.1 Right to win 346 15.1.2.4.2 Strategic choices 346 15.1.2.4.3 Weaknesses & competitive threats 347 15.1.3 OLYMPUS CORPORATION 348 15.1.3.1 Business overview 348 15.1.3.2 Products offered 349 15.1.3.3 Recent developments 350 15.1.3.3.1 Deals 350 15.1.3.3.2 Other developments 351 15.1.3.4 MnM view 352 15.1.3.4.1 Right to win 352 15.1.3.4.2 Strategic choices 352 15.1.3.4.3 Weaknesses & competitive threats 352 15.1.4 M.I. TECH 353 15.1.4.1 Business overview 353 15.1.4.2 Products offered 354 15.1.4.3 Recent developments 356 15.1.4.3.1 Deals 356 15.1.4.4 MnM view 356 15.1.4.4.1 Right to win 356 15.1.4.4.2 Strategic choices 356 15.1.4.4.3 Weaknesses & competitive threats 356 15.1.5 MICRO-TECH (NANJING) CO., LTD. 357 15.1.5.1 Business overview 357 15.1.5.2 Products offered 358 15.1.5.3 Recent developments 359 15.1.5.3.1 Deals 359 15.1.5.3.2 Expansions 359 15.1.5.4 MnM view 360 15.1.5.4.1 Right to win 360 15.1.5.4.2 Strategic choices 360 15.1.5.4.3 Weaknesses & competitive threats 360 15.1.6 MERIT MEDICAL SYSTEMS 361 15.1.6.1 Business overview 361 15.1.6.2 Products offered 363 15.1.6.3 Recent developments 363 15.1.6.3.1 Product launches & approvals 363 15.1.7 MEDTRONIC 364 15.1.7.1 Business overview 364 15.1.7.2 Products offered 365   15.1.8 ELLA–CS, S.R.O. 366 15.1.8.1 Business overview 366 15.1.8.2 Products offered 366 15.1.8.3 Recent developments 367 15.1.8.3.1 Product launches 367 15.1.8.3.2 ther developments 368 15.1.9 STERIS 369 15.1.9.1 Business overview 369 15.1.9.2 Products offered 370 15.1.10 W. L. GORE & ASSOCIATES, INC. 371 15.1.10.1 Business overview 371 15.1.10.2 Products offered 371 15.1.10.3 Recent developments 372 15.1.10.3.1 Deals 372 15.1.11 BD 373 15.1.11.1 Business overview 373 15.1.11.2 Products offered 375 15.1.12 Q3 MEDICAL GROUP 376 15.1.12.1 Business overview 376 15.1.12.2 Products offered 377 15.1.12.3 Recent developments 378 15.1.12.3.1 Product approvals & enhancements 378 15.1.12.3.2 Other developments 379 15.1.13 MEDI-GLOBE GMBH 380 15.1.13.1 Business overview 380 15.1.13.2 Products offered 381 15.1.14 HOBBS MEDICAL INC. 382 15.1.14.1 Business overview 382 15.1.14.2 Products offered 382 15.1.15 BVM 383 15.1.15.1 Business overview 383 15.1.15.2 Products offered 383 15.2 OTHER PLAYERS 385 15.2.1 LEUFEN 385 15.2.2 ALLIUM 386 15.2.3 MEDORAH MEDITEK PVT. LTD. 387 15.2.4 MITRA INDUSTRIES 388 15.2.5 ENDOGI MEDICAL 389 15.2.6 ADVIN HEALTH CARE 390 15.2.7 HUNAN FUDE TECHNOLOGY CO., LTD. 391 15.2.8 HOSPI LINE EQUIPMENTS PVT. LTD. 392 15.2.9 CITEC 392 15.2.10 G-FLEX 393 16 RESEARCH METHODOLOGY 394 16.1 RESEARCH DATA 394 16.1.1 SECONDARY DATA 395 16.1.1.1 Key secondary sources 396 16.1.2 PRIMARY DATA 396 16.1.3 PRIMARY SOURCES 397 16.1.3.1 Key data from primary sources 398 16.1.3.2 Key industry insights 399 16.1.3.3 Breakdown of primaries 399 16.2 MARKET SIZE ESTIMATION 401 16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 403 16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 404 16.2.3 APPROACH 3: TOP-DOWN APPROACH 405 16.2.4 APPROACH 4: BOTTOM-UP APPROACH 405 16.2.5 APPROACH 5: PRIMARY INTERVIEWS 406 16.2.6 APPROACH 6: DEMAND-SIDE APPROACH 406 16.2.7 APPROACH 7: VOLUME DATA ANALYSIS 407 16.3 DATA TRIANGULATION & MARKET BREAKDOWN 410 16.4 MARKET SHARE ASSESSMENT 411 16.5 RESEARCH ASSUMPTIONS 411 16.5.1 STUDY ASSUMPTIONS 411 16.5.2 GROWTH RATE ASSUMPTIONS 411 16.6 RISK ASSESSMENT 412 16.6.1 RESEARCH LIMITATIONS 412 17 APPENDIX 413 17.1 DISCUSSION GUIDE 413 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 418 17.3 CUSTOMIZATION OPTIONS 420 17.3.1 PRODUCT ANALYSIS 420 17.3.2 COMPANY INFORMATION 420 17.3.3 GEOGRAPHIC ANALYSIS 420 17.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 420 17.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT 420 17.3.6 MARKET SHARE ANALYSIS, BY PRODUCT (TOP 5 PLAYERS) 420 17.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 420 17.4 RELATED REPORTS 421 17.5 AUTHOR DETAILS 422

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 38 TABLE 2 GASTROINTESTINAL STENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 63 TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 66 TABLE 4 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023–2025 71 TABLE 5 AVERAGE SELLING PRICE TREND OF NITINOL STENTS, BY REGION, 2023−2025 74 TABLE 6 AVERAGE SELLING PRICE TREND OF STAINLESS-STEEL STENTS, BY REGION, 2023−2025 74 TABLE 7 AVERAGE SELLING PRICE TREND OF PLASTIC STENTS, BY REGION, 2023−2025 74 TABLE 8 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 75 TABLE 9 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 76 TABLE 10 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021–2025 (USD THOUSAND) 76 TABLE 11 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021–2025 (USD THOUSAND) 77 TABLE 12 GASTROINTESTINAL STENTS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027 77 TABLE 13 CASE STUDY 1: COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION 80 TABLE 14 CASE STUDY 2: DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION 80 TABLE 15 CASE STUDY 3: LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION 81 TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 83 TABLE 17 KEY PRODUCT-RELATED TARIFFS 83 TABLE 18 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 84 TABLE 19 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 85 TABLE 20 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 85 TABLE 21 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 86 TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROINTESTINAL STENTS 94 TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS 96 TABLE 28 KEY DIFFERENCES BETWEEN BIODEGRADABLE & NON-BIODEGRADABLE METAL STENTS 99 TABLE 29 GASTROINTESTINAL STENTS MARKET: MAJOR PATENTS 106 TABLE 30 KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET 110 TABLE 31 GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 112 TABLE 32 GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 112 TABLE 33 KEY PLAYERS OFFERING BILIARY STENTS 114 TABLE 34 BILIARY STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 35 KEY PLAYERS PROVIDING ESOPHAGEAL STENTS 116 TABLE 36 ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 37 KEY PLAYERS PROVIDING COLONIC STENTS 118 TABLE 38 COLONIC STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 39 KEY PLAYERS PROVIDING DUODENAL STENTS 120 TABLE 40 DUODENAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 41 KEY PLAYERS PROVIDING PANCREATIC STENTS 122 TABLE 42 PANCREATIC STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 43 GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125 TABLE 44 KEY PLAYERS PROVIDING METAL STENTS 126 TABLE 45 METAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 46 METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128 TABLE 47 NITINOL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 48 NITINOL STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 130 TABLE 49 STAINLESS STEEL STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 131 TABLE 50 STAINLESS STEEL STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 132 TABLE 51 OTHER METAL STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 133 TABLE 52 METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 134 TABLE 53 SELF-EXPANDING METAL STENTS (SEMS) MARKET, BY COUNTRY, 2024–2031(USD MILLION) 135 TABLE 54 BALLOON-EXPANDABLE METAL STENTS (BEMS) MARKET, BY COUNTRY, 2024–2031(USD MILLION) 136 TABLE 55 METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 137 TABLE 56 UNCOVERED STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 138 TABLE 57 FULLY COVERED STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 58 PARTIALLY COVERED STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 142 TABLE 59 KEY PLAYERS PROVIDING PLASTIC STENTS 143 TABLE 60 PLASTIC STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 61 PLASTIC STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 145 TABLE 62 KEY PLAYERS PROVIDING BIODEGRADABLE STENTS 146 TABLE 63 BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 64 BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 65 BIODEGRADABLE STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 148 TABLE 66 POLYMER-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 67 MAGNESIUM-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 68 OTHER BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 69 GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 155 TABLE 70 GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 71 GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 72 GASTROINTESTINAL STENTS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 73 GASTROINTESTINAL STENTS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 74 GASTROINTESTINAL STENTS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 75 GASTROINTESTINAL STENTS MARKET FOR STOMACH CANCER, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 76 GASTROINTESTINAL STENTS MARKET FOR BILIARY DISEASE, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 77 GASTROINTESTINAL STENTS MARKET FOR BENIGN STRICTURES & LEAKS, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 78 GASTROINTESTINAL STENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 79 GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 171 TABLE 80 GASTROINTESTINAL STENTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 81 GASTROINTESTINAL STENTS MARKET FOR SPECIALTY ENDOSCOPY CENTERS/ GI CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 82 GASTROINTESTINAL STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 83 GASTROINTESTINAL STENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 84 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 181 TABLE 85 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 86 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 181 TABLE 87 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 88 NORTH AMERICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 89 NORTH AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 182 TABLE 90 NORTH AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 183 TABLE 91 NORTH AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 183 TABLE 92 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 183 TABLE 93 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 184 TABLE 94 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 184 TABLE 95 US: KEY MACROINDICATORS 185 TABLE 96 US: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 186 TABLE 97 US: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 98 US: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 99 US: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 187 TABLE 100 US: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 187 TABLE 101 US: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 102 US: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 188 TABLE 103 US: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 104 US: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 188 TABLE 105 CANADA: KEY MACROINDICATORS 190 TABLE 106 CANADA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 190 TABLE 107 CANADA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 190 TABLE 108 CANADA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 109 CANADA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 191 TABLE 110 CANADA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 191 TABLE 111 CANADA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 112 CANADA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 192 TABLE 113 CANADA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 114 CANADA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 193 TABLE 115 EUROPE: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 194 TABLE 116 EUROPE: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 117 EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195 TABLE 118 EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 119 EUROPE: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 120 EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 196 TABLE 121 EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 196 TABLE 122 EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 123 EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197 TABLE 124 EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 125 EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 198 TABLE 126 GERMANY: KEY MACROINDICATORS 199 TABLE 127 GERMANY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 199 TABLE 128 GERMANY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 129 GERMANY: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 130 GERMANY: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 200 TABLE 131 GERMANY: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 201 TABLE 132 GERMANY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 133 GERMANY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 201 TABLE 134 GERMANY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 135 GERMANY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 202 TABLE 136 UK: KEY MACROINDICATORS 203 TABLE 137 UK: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 204 TABLE 138 UK: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 139 UK: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 140 UK: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 205 TABLE 141 UK: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 205 TABLE 142 UK: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 143 UK: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 206 TABLE 144 UK: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 145 UK: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 206 TABLE 146 FRANCE: KEY MACROINDICATORS 207 TABLE 147 FRANCE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 208 TABLE 148 FRANCE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 149 FRANCE: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 150 FRANCE: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 209 TABLE 151 FRANCE: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 209 TABLE 152 FRANCE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 153 FRANCE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 210 TABLE 154 FRANCE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 155 FRANCE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 210 TABLE 156 ITALY: KEY MACROINDICATORS 211 TABLE 157 ITALY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 212 TABLE 158 ITALY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 159 ITALY: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 160 ITALY: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 213 TABLE 161 ITALY: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 213 TABLE 162 ITALY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 163 ITALY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 214 TABLE 164 ITALY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 165 ITALY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 214 TABLE 166 SPAIN: KEY MACROINDICATORS 215 TABLE 167 SPAIN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 216 TABLE 168 SPAIN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 169 SPAIN: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 170 SPAIN: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 217 TABLE 171 SPAIN: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 217 TABLE 172 SPAIN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 173 SPAIN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 218 TABLE 174 SPAIN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 175 SPAIN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 218 TABLE 176 NETHERLANDS: KEY MACROINDICATORS 219 TABLE 177 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 220 TABLE 178 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 179 NETHERLANDS: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 180 NETHERLANDS: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 221 TABLE 181 NETHERLANDS: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 221 TABLE 182 NETHERLANDS: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 183 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 222 TABLE 184 NETHERLANDS: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 185 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 222 TABLE 186 SWEDEN: KEY MACROINDICATORS 223 TABLE 187 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 224 TABLE 188 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 189 SWEDEN: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 190 SWEDEN: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 225 TABLE 191 SWEDEN: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 225 TABLE 192 SWEDEN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 193 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 226 TABLE 194 SWEDEN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 195 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 226 TABLE 196 POLAND: KEY MACROINDICATORS 227 TABLE 197 POLAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 228 TABLE 198 POLAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 199 POLAND: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 200 POLAND: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 229 TABLE 201 POLAND: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 229 TABLE 202 POLAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 203 POLAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 230 TABLE 204 POLAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 205 POLAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 230 TABLE 206 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 231 TABLE 207 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 208 REST OF EUROPE: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 209 REST OF EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 232 TABLE 210 REST OF EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 233 TABLE 211 REST OF EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 212 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 233 TABLE 213 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 214 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 234 TABLE 215 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 236 TABLE 216 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 217 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 237 TABLE 218 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 219 ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 220 ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 238 TABLE 221 ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 238 TABLE 222 ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 223 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 239 TABLE 224 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 225 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 240 TABLE 226 CHINA: KEY MACROINDICATORS 241 TABLE 227 CHINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 241 TABLE 228 CHINA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 229 CHINA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 230 CHINA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 242 TABLE 231 CHINA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 243 TABLE 232 CHINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 233 CHINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 243 TABLE 234 CHINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 235 CHINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 244 TABLE 236 JAPAN: KEY MACROINDICATORS 245 TABLE 237 JAPAN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 246 TABLE 238 JAPAN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 239 JAPAN: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 240 JAPAN: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 247 TABLE 241 JAPAN: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 247 TABLE 242 JAPAN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 243 JAPAN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 248 TABLE 244 JAPAN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 245 JAPAN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 248 TABLE 246 INDIA: KEY MACROINDICATORS 250 TABLE 247 INDIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 250 TABLE 248 INDIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 249 INDIA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 250 INDIA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 251 TABLE 251 INDIA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 251 TABLE 252 INDIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 253 INDIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 252 TABLE 254 INDIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 255 INDIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 253 TABLE 256 AUSTRALIA: KEY MACROINDICATORS 254 TABLE 257 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 254 TABLE 258 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 259 AUSTRALIA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 260 AUSTRALIA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 255 TABLE 261 AUSTRALIA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 255 TABLE 262 AUSTRALIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 263 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 256 TABLE 264 AUSTRALIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 265 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 257 TABLE 266 SOUTH KOREA: KEY MACROINDICATORS 258 TABLE 267 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 258 TABLE 268 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 269 SOUTH KOREA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 270 SOUTH KOREA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 259 TABLE 271 SOUTH KOREA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 260 TABLE 272 SOUTH KOREA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 273 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 260 TABLE 274 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 275 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 261 TABLE 276 THAILAND: KEY MACROINDICATORS 262 TABLE 277 THAILAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 263 TABLE 278 THAILAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 279 THAILAND: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 280 THAILAND: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 264 TABLE 281 THAILAND: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 264 TABLE 282 THAILAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 283 THAILAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 265 TABLE 284 THAILAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 285 THAILAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 265 TABLE 286 NEW ZEALAND: KEY MACROINDICATORS 266 TABLE 287 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 267 TABLE 288 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 289 NEW ZEALAND: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 290 NEW ZEALAND: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 268 TABLE 291 NEW ZEALAND: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 268 TABLE 292 NEW ZEALAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 293 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 269 TABLE 294 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 295 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 269 TABLE 296 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 270 TABLE 297 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 298 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 299 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 271 TABLE 300 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 272 TABLE 301 REST OF ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 302 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 272 TABLE 303 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 304 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 273 TABLE 305 LATIN AMERICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 275 TABLE 306 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 307 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 275 TABLE 308 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 309 LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 310 LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 276 TABLE 311 LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 277 TABLE 312 LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 313 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 277 TABLE 314 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 315 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 278 TABLE 316 BRAZIL: KEY MACROINDICATORS 279 TABLE 317 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 280 TABLE 318 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 319 BRAZIL: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 320 BRAZIL: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 281 TABLE 321 BRAZIL: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 281 TABLE 322 BRAZIL: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 323 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 282 TABLE 324 BRAZIL: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 325 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 282 TABLE 326 MEXICO: KEY MACROINDICATORS 283 TABLE 327 MEXICO: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 284 TABLE 328 MEXICO: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 329 MEXICO: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 330 MEXICO: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 285 TABLE 331 MEXICO: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 285 TABLE 332 MEXICO: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 333 MEXICO: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 286 TABLE 334 MEXICO: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 335 MEXICO: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 286 TABLE 336 ARGENTINA: KEY MACROINDICATORS 287 TABLE 337 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 288 TABLE 338 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 339 ARGENTINA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 340 ARGENTINA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 289 TABLE 341 ARGENTINA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 289 TABLE 342 ARGENTINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 343 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 290 TABLE 344 ARGENTINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 345 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 290 TABLE 346 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 291 TABLE 347 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 348 REST OF LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 349 REST OF LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 292 TABLE 350 REST OF LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 293 TABLE 351 REST OF LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 352 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 293 TABLE 353 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 354 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 294 TABLE 355 MIDDLE EAST & AFRICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 295 TABLE 356 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 296 TABLE 357 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 296 TABLE 358 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 359 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 360 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 297 TABLE 361 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 297 TABLE 362 MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 363 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 298 TABLE 364 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 365 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 299 TABLE 366 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 367 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 300 TABLE 368 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 369 GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 370 GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 301 TABLE 371 GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 301 TABLE 372 GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 373 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 302 TABLE 374 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 375 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 303 TABLE 376 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 304 TABLE 377 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 304 TABLE 378 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 379 KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 380 KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 305 TABLE 381 KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 306 TABLE 382 KINGDOM OF SAUDI ARABIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 383 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 306 TABLE 384 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 385 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 307 TABLE 386 UNITED ARAB EMIRATES: KEY MACROINDICATORS 308 TABLE 387 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 308 TABLE 388 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 389 UNITED ARAB EMIRATES: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 390 UNITED ARAB EMIRATES: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 309 TABLE 391 UNITED ARAB EMIRATES: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 310 TABLE 392 UNITED ARAB EMIRATES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 393 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 310 TABLE 394 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 395 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 311 TABLE 396 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 312 TABLE 397 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 398 REST OF GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 399 REST OF GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 313 TABLE 400 REST OF GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 313 TABLE 401 REST OF GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 402 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 314 TABLE 403 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 404 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 315 TABLE 405 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 316 TABLE 406 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 407 REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 408 REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 317 TABLE 409 REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION) 317 TABLE 410 REST OF MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 411 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 318 TABLE 412 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 413 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 318 TABLE 414 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET 319 TABLE 415 GASTROINTESTINAL STENTS MARKET: DEGREE OF COMPETITION 322 TABLE 416 GASTROINTESTINAL STENTS MARKET: REGION FOOTPRINT 328 TABLE 417 GASTROINTESTINAL STENTS MARKET: PRODUCT FOOTPRINT 329 TABLE 418 GASTROINTESTINAL STENTS MARKET: TYPE FOOTPRINT 329 TABLE 419 GASTROINTESTINAL STENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES 332 TABLE 420 GASTROINTESTINAL STENTS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 333 TABLE 421 GASTROINTESTINAL STENTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 336 TABLE 422 GASTROINTESTINAL STENTS MARKET: DEALS, JANUARY 2022–MAY 2026 337 TABLE 423 GASTROINTESTINAL STENTS MARKET: EXPANSIONS, JANUARY 2022–MAY 2026 338 TABLE 424 GASTROINTESTINAL STENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 338 TABLE 425 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 340 TABLE 426 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 341 TABLE 427 COOK MEDICAL: COMPANY OVERVIEW 344 TABLE 428 COOK MEDICAL: PRODUCTS OFFERED 345 TABLE 429 COOK MEDICAL: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 346 TABLE 430 OLYMPUS CORPORATION: COMPANY OVERVIEW 348 TABLE 431 OLYMPUS CORPORATION: PRODUCTS OFFERED 349 TABLE 432 OLYMPUS CORPORATION: DEALS, JANUARY 2023–MAY 2026 350 TABLE 433 OLYMPUS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 351 TABLE 434 M.I. TECH: COMPANY OVERVIEW 353 TABLE 435 M.I. TECH: PRODUCTS OFFERED 354 TABLE 436 M.I. TECH: DEALS, JANUARY 2022–MAY 2026 356 TABLE 437 MICRO-TECH (NANJING) CO., LTD.: COMPANY OVERVIEW 357 TABLE 438 MICRO-TECH (NANJING) CO., LTD.: PRODUCTS OFFERED 358 TABLE 439 MICRO-TECH (NANJING) CO., LTD.: DEALS, JANUARY 2022–MAY 2026 359 TABLE 440 MICRO-TECH (NANJING) CO., LTD.: EXPANSIONS, JANUARY 2022–MAY 2026 359 TABLE 441 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 361 TABLE 442 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 363 TABLE 443 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022- MAY 2026 363 TABLE 444 MEDTRONIC: COMPANY OVERVIEW 364 TABLE 445 MEDTRONIC : PRODUCTS OFFERED 365 TABLE 446 ELLA–CS, S.R.O.: COMPANY OVERVIEW 366 TABLE 447 ELLA–CS, S.R.O.: PRODUCTS OFFERED 366 TABLE 448 ELLA–CS, S.R.O.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 367 TABLE 449 ELLA–CS, S.R.O.: OTHER DEVELOPMENTS, JANUARY 2023−MAY 2026 368 TABLE 450 STERIS: COMPANY OVERVIEW 369 TABLE 451 STERIS: PRODUCTS OFFERED 370 TABLE 452 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 371 TABLE 453 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED 371 TABLE 454 W. L. GORE & ASSOCIATES, INC.: DEALS, JANUARY 2022–MAY 2026 372 TABLE 455 BD: COMPANY OVERVIEW 373 TABLE 456 BD: PRODUCTS OFFERED 375 TABLE 457 Q3 MEDICAL GROUP: COMPANY OVERVIEW 376 TABLE 458 Q3 MEDICAL GROUP: PRODUCTS OFFERED 377 TABLE 459 Q3 MEDICAL GROUP: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2023–MAY 2026 378 TABLE 460 Q3 MEDICAL GROUP: OTHER DEVELOPMENTS, JANUARY 2023−MAY 2026 379 TABLE 461 MEDI-GLOBE GMBH: COMPANY OVERVIEW 380 TABLE 462 MEDI-GLOBE GMBH: PRODUCTS OFFERED 381 TABLE 463 HOBBS MEDICAL INC.: COMPANY OVERVIEW 382 TABLE 464 HOBBS MEDICAL INC.: PRODUCTS OFFERED 382 TABLE 465 BVM: COMPANY OVERVIEW 383 TABLE 466 BVM: PRODUCTS OFFERED 383 TABLE 467 STUDY ASSUMPTIONS 411 TABLE 468 RISK ASSESSMENT ANALYSIS 412 FIGURE 1 GASTROINTESTINAL STENTS MARKET SEGMENTATION & REGIONAL SCOPE 36 FIGURE 2 MARKET SCENARIO 41 FIGURE 3 GLOBAL GASTROINTESTINAL STENTS MARKET, 2024–2031 42 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET, 2023–2025 43 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF GASTROINTESTINAL STENTS MARKET 43 FIGURE 6 HIGH-GROWTH SEGMENTS IN GASTROINTESTINAL STENTS MARKET, 2026–2031 44 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GASTROINTESTINAL STENTS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 45 FIGURE 8 STRONG FUTURE FOR MINIMALLY INVASIVE AND ADVANCED GASTROINTESTINAL INTERVENTIONS TO BOOST MARKET GROWTH 47 FIGURE 9 METAL STENTS AND CHINA DOMINATED MARKET IN 2025 48 FIGURE 10 APAC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 49 FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 49 FIGURE 12 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 50 FIGURE 13 GASTROINTESTINAL STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 14 GASTROINTESTINAL STENTS MARKET: PORTER'S FIVE FORCES ANALYSIS 63 FIGURE 15 GASTROINTESTINAL STENTS MARKET: VALUE CHAIN ANALYSIS 69 FIGURE 16 GASTROINTESTINAL STENTS MARKET: ECOSYSTEM ANALYSIS 70 FIGURE 17 AVERAGE SELLING PRICE OF PLASTIC BILIARY STENTS, BY KEY PLAYER, 2025 72 FIGURE 18 AVERAGE SELLING PRICE OF GASTROINTESTINAL STENTS, BY REGION, 2025 73 FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78 FIGURE 20 GASTROINTESTINAL STENTS MARKET: INVESTMENT & FUNDING SCENARIO 79 FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROINTESTINAL STENTS 94 FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 95 FIGURE 23 GASTROINTESTINAL STENTS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015–MAY 2026) 105 FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR GASTROINTESTINAL STENT PATENTS (JANUARY 2015–MAY 2026) 106 FIGURE 25 AI USE CASES 109 FIGURE 26 GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC SNAPSHOT 178 FIGURE 27 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET SNAPSHOT 180 FIGURE 28 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET SNAPSHOT 236 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET (2023−2025) 321 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET, 2025 322 FIGURE 31 US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025 324 FIGURE 32 EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025 324 FIGURE 33 GASTROINTESTINAL STENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 326 FIGURE 34 GASTROINTESTINAL STENTS MARKET: COMPANY FOOTPRINT 327 FIGURE 35 GASTROINTESTINAL STENTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2025 331 FIGURE 36 EV/EBITDA OF KEY VENDORS 334 FIGURE 37 5-YEAR STOCK BETA OF KEY VENDORS 334 FIGURE 38 BRAND/PRODUCT COMPARATIVE ANALYSIS 335 FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 341 FIGURE 40 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2025) 349 FIGURE 41 M.I. TECH: COMPANY SNAPSHOT (2025) 353 FIGURE 42 MICRO-TECH (NANJING) CO., LTD.: COMPANY SNAPSHOT (2025) 357 FIGURE 43 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025) 362 FIGURE 44 MEDTRONIC: COMPANY SNAPSHOT (2025) 365 FIGURE 45 STERIS: COMPANY SNAPSHOT (2025) 370 FIGURE 46 BD: COMPANY SNAPSHOT (2025) 374 FIGURE 47 GASTROINTESTINAL STENTS MARKET: RESEARCH DESIGN 394 FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 399 FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 400 FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 400 FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 402 FIGURE 52 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 403 FIGURE 53 REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION (2025) 404 FIGURE 54 TOP-DOWN APPROACH 405 FIGURE 55 BOTTOM-UP APPROACH 405 FIGURE 56 DEMAND-SIDE APPROACH 407 FIGURE 57 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GASTROINTESTINAL STENTS MARKET (2026–2031) 408 FIGURE 58 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 409 FIGURE 59 DATA TRIANGULATION METHODOLOGY 410